(Q40177463)

18 September 2017

1 reference

title

Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy (English)

1 reference

18 September 2017

Iron Overload Disorders: Natural History, Pathogenesis, Diagnosis, and Therapy (English)

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

10 October 2023

1 reference

G. D. McLaren

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6373141

10 October 2023

W. A. Muir

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6373141

10 October 2023

R. W. Kellermeyer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6373141

10 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6373141

10 October 2023

publication date

1 January 1983

1 reference

full work available at URL

18 September 2017

http://www.tandfonline.com/doi/pdf/10.3109/10408368309165764

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Critical Reviews in Clinical Laboratory Sciences

10 October 2023

published in

1 reference

18 September 2017

19

1 reference

18 September 2017

3

1 reference

18 September 2017

205-266

1 reference

Changing concepts in haemochromatosis

18 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Hereditary hemochromatosis. Phenotypic expression of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Hepatoma developing in hemochromatosis in spite of adequate treatment by multiple phlebotomies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Normal and abnormal regulation of beta-msh in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Insulin-resistant diabetes mellitus associated with hemochromatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Action of prednisone in insulin-resistant diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Iron Excess, Early Glucose Intolerance and Impaired Insulin Secretion in Idiopathic Haemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Pituitary function in haemochromatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Pituitary function in idiopathic haemochromatosis and cirrhosis of the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

An investigation into gonadal dysfunction in patients with idiopathic haemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Synovial biopsy in haemochromatosis arthropathy. Histological findings and iron deposition in relation to total body iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Hemochromatosis: a disease often silent but not invisible

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

The Arthropathy of Hemochromatosis Without Hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Arthropathy, hypouricemia and normal serum iron studies in hereditary hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Osteoporosis, scurvy, and siderosis in Johannesburg bantu.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Effects of Iron Overload on Ascorbic Acid Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Ascorbic acid catabolism in Bantu with hemosiderosis (scurvy)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

The effect of siderosis and ascorbic acid depletion on bone metabolism, with special reference to osteoporosis in the Bantu

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Hemochromatosis and heart failure: presentation of a case with survival after three years' treatment by repeated venesection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Haemochromatosis presenting as congestive cardiomyopathy and responding to venesection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Iron and susceptibility to infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Disease caused by a marine Vibrio. Clinical characteristics and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Suppressive Effect of Ferritin on in Vitro Lymphocyte Function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

SUPPRESSION HEMATOPOIESIS BY ETHANOL.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Gluconate metabolism of Pasteurellapestis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Familial hemochromatosis. Physiologic studies in the precirrhotic stage of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Hereditary hemochromatosis. Diagnosis in siblings and children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Letter: HLA antigens in haemochromatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Idiopathic hemochromatosis: linkage with HLA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Serum Ferritin as a Possible Marker of the Hemochromatosis Allele

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Hepatic cirrhosis: a clinico-pathological review of 520 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Histocompatibility antigens as markers of abnormal iron metabolism in patients with idiopathic haemochromatosis and their relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Internal regulation of iron absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Iron absorption in normal subjects and patients with idiopathic haemochromatosis: relationship with serum ferritin concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

The Effect of Enteral and Parenteral Iron on Ferritin Synthesis in the Intestinal Mucosa of the Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Iron-binding properties of gastric juice in idiopathic haemochromatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Intestinal mucosal uptake of iron and iron retention in idiopathic haemochromatosis as evidence for a mucosal abnormality

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Mechanism of release of ferritin iron in vivo by xanthine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Uptake of iron by duodenal biopsy specimens from patients with iron-deficiency anaemia and primary haemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Diurnal Variations of the Serum Iron in Normal Subjects and in Patients with Haemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Abnormality in tissue isoferritin distribution in idiopathic haemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Alterations in tissue ferritins in iron storage disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Transferrin iron, chelatable iron and ferritin in idiopathic haemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Studies on the concentration and intracellular localization of iron proteins in liver biopsy specimens from patients with iron overload with special reference to their role in lysosomal disruption.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Iron uptake and ferritin synthesis by peripheral blood leucocytes in patients with primary idiopathic haemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

The quantitative estimation of total iron stores in human bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Patterns of Food Iron Absorption in Iron‐Deficient White and Indian Subjects and in Venesected Haemochromatotic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Ultrastructural characteristics of the synovial membrane in idiopathic haemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Effect of ethionine-induced pancreatic damage on iron absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Experimental hepatic cirrhosis in dogs caused by chronic massive iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Mechanisms of lipid peroxide formation in animal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Hepatic lipid peroxidation in vivo in rats with chronic iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Effects of desferrioxamine in patients with iron-loading with a simple method for estimating urinary iron

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Differential ferrioxamine test in idiopathic haemochromatosis and transfusional haemosiderosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Use of diethylenetriamine penta-acetic acid (D.T.P.A.) in the clinical assessment of total body iron stores

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Differential ferrioxamide test in haemochromatosis and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Quantitative measurement of iron stores with diethylenetriamine penta-acetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Measurement of iron stores in cirrhosis using diethylenetriamine penta-acetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Measurement of serum ferritin by a 2-site immunoradiometric assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

A clinical evaluation of serum ferritin as an index of iron stores

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Characterization of serum ferritin in iron overload: possible identity to natural apoferritin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

The Kinetics of Serum and Tissue Ferritins: Relation to Carbohydrate Content

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Immunological detection of isoferritins in normal human serum and tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Serum Ferritin in Haemochromatosis: Changes in the Isoferritin Composition during Venesection Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Serum ferritin concentration and iron stores in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Serum ferritin in children with thalassaemia regularly transfused

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Relationship between serum ferritin and total body iron stores in idiopathic haemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Normal Serum Ferritin Concentrations in Precirrhotic Hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Serum-ferritin in diagnosis of haemochromatosis. A study of 43 families

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Early detection of idiopathic haemochromatosis: relative value of serum-ferritin and HLA typing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Significance for the diagnosis of iron overload of histochemical and chemical iron in the liver of control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Relationship of hepatic iron concentration to histochemical grading and to total chelatable body iron in conditions associated with iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Correlation between computed tomographic values and liver iron content in thalassaemia major with iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical Progress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Prevention of iron loading in transfusion-dependent thalassaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Response to long-term deferoxamine therapy in thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Inhibition of Membrane Peroxidation in Thalassaemic Erythrocytes by 2,3-Dihydroxybenzoic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Liposome entrapped desferrioxamine and iron transporting ionophores: a new approach to iron chelation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Prevention of bone malformations and cardiomegaly in Cooley's anemia by early hypertransfusion regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Human ferritin gene is assigned to chromosome 19

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Iron Intake and Hæmochromatosis in the Bantu

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368309165764

Idiopathic hemochromatosis, an iron storage disease. A. Iron metabolism in hemochromatosis

21 January 2018

5

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Idiopathic hemochromatosis. A variant of portal cirrhosis and idiopathic hemosiderosis

10 October 2023

17

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing

10 October 2023

19

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

IDIOPATHIC HAEMOCHROMATOSIS IN CHILDREN; REPORT OF A FAMILY

10 October 2023

28

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Hemochromatosis: Pathophysiologic and Genetic Considerations

10 October 2023

29

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Liver biopsy in diagnosis of hemochromatosis

10 October 2023

32

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

The treatment of hemochromatosis by phlebotomy.

10 October 2023

35

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Hydatid disease notifications in New South Wales

10 October 2023

36

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

10 October 2023

39

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Occurrence and prevalence of diabetic retinopathy in hemochromatosis

10 October 2023

49

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Idiopathic hemochromatosis presenting as malabsorption syndrome: Report of a case

10 October 2023

51

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Hemochromatosis; investigation of twenty-three cases, with special reference to etiology, nutrition, iron metabolism, and studies of hepatic and pancreatic function

10 October 2023

56

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

HEMOCHROMATOSIS AND ARTHRITIS

10 October 2023

57

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Unusual connective tissue manifestations of hemochromatosis

10 October 2023

60

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Hemochromatotic arthropathy mimicking rheumatoid arthritis. A case with subcutaneous nodules, tenosynovitis, and bursitis

10 October 2023

61

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Arthropathy of hemochromatosis

10 October 2023

66

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Scurvy and altered iron stores in thalassemia major

10 October 2023

71

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Accelerated Oxidative Catabolism of Ascorbic Acid in Siderotic Bantu

10 October 2023

72

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

The heart in hemochromatosis

10 October 2023

76

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Reversible Cardiomyopathy Associated with Hemochromatosis

10 October 2023

80

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Clinical consequences of acquired transfusional iron overload in adults

10 October 2023

82

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Iron absorption in the thalassemia syndromes and its inhibition by tea

10 October 2023

83

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Iron and Susceptibility to Infectious Disease

10 October 2023

89

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Immunity, transferrin, and survival in kwashiorkor

10 October 2023

91

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Iron deficiency anemia of infancy: some clinical principles illustrated by the response of Maori infants to neonatal parenteral iron administration

10 October 2023

92

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload.

10 October 2023

95

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Idiopathic hemochromatosis, an interim report.

10 October 2023

97

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Clinical Evaluation of Iron Stores

10 October 2023

101

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

High Incidence of Extrahepatic Carcinomas in Idiopathic Hemochromatosis

10 October 2023

105

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Hereditary iron-loading anemia with secondary hemochromatosis

10 October 2023

109

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

A familial study in idiopathic hemochromatosis

10 October 2023

110

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Hepatic pathology in relatives of patients with hæmochromatosis

10 October 2023

113

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Familial occurrence of hemochromatosis: report of four cases in siblings

10 October 2023

114

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Familial aspects of idiopathic hemochromatosis

10 October 2023

115

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Hemochromatosis in two young sisters. Case studies and a family survey

10 October 2023

119

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Genetics of haemochromatosis

10 October 2023

120

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Idiopathic hemochromatosis. A study of three families

10 October 2023

122

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Inheritance of haemochromatosis. A report on a family with consanguinity

10 October 2023

123

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Letter: HLA antigens in haemochromatosis

10 October 2023

129

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Idiopathic Hemochromatosis and Iron Overload in Alcoholic Liver Disease: Differentiation by HLA Phenotype

10 October 2023

133

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Genetic mapping of the hemochromatosis locus on chromosome six

10 October 2023

137

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Genetics of Hemochromatosis

10 October 2023

140

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis

10 October 2023

144

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda

10 October 2023

150

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

The enzymatic defect in porphyria cutanea tarda

10 October 2023

151

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Red-cell uroporphyrinogen decarboxylase activity in porphyria cutanea tarda and in other forms of porphyria

10 October 2023

152

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Porphyria Cutanea Tarda in Three Generations of a Single Family

10 October 2023

154

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

HLA-types in porphyria cutanea tarda

10 October 2023

155

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

iron-overload-associated myopathy in patients on maintenance haemodialysis: a histocompatibility-linked disorder

10 October 2023

156

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Food iron absorption from pork, porcine liver and porcine hemoglobin in men with normal and depleted iron stores. Studies on dietary iron deficiency prevention and therapy

10 October 2023

159

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Gastric intrinsic factor and iron absorption

10 October 2023

161

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Site of iron absorption in man

10 October 2023

162

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Ferritin; its properties and significance for iron metabolism.

10 October 2023

164

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Iron Absorption in Idiopathic Haemochromatosis before, during, and after Venesection Therapy

10 October 2023

169

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

RELATIONSHIP OF DIMINISHED PANCREATIC SECRETION TO HAEMOCHROMATOSIS

10 October 2023

172

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Reduction of gastric iron-binding protein in haemochromatosis. A previously unrecognised metabolic defect

10 October 2023

175

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Gastric iron binding in haemochromatosis, secondary iron overload, cirrhosis, and diabetes

10 October 2023

176

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Studies on an iron-binding component in human gastric juice

10 October 2023

179

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Iron Absorption, Iron Loss and Iron Retention in Man: Studies after Oral Administration of a Tracer Dose of59FeSO4and131BaSO4

10 October 2023

183

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

XANTHINURIA AND HEMOCHROMATOSIS

10 October 2023

185

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Effect of a xanthine-oxidase inhibitor (allopurinol) on radioiron absorption in man

10 October 2023

188

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

The kinetics of iron uptake in vitro by human duodenal mucosa: studies in normal subjects

10 October 2023

189

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Cellular mechanisms in the regulation of iron absorption by the human intestine: studies in patients with iron deficiency before and after treatment

10 October 2023

190

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

The New England Journal of Medicine

10 October 2023

193

302

695

Cox T. M

1980

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Mucosal Uptake, Mucosal Transfer and Retention of Iron, Measured by Whole-Body Counting

10 October 2023

194

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

A non-transferrin-bound serum iron in idiopathic hemochromatosis

10 October 2023

203

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Metabolic and molecular heterogeneity of marrow ferritin

10 October 2023

218

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Properties of human tissue isoferritins

10 October 2023

219

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

The reactivity of isoferritins in a labelled antibody assay

10 October 2023

220

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Changes in the characteristics and distribution of ferritin in iron-loaded cell cultures

10 October 2023

221

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

The organ-specificity of ferritin in human and horse liver and spleen

10 October 2023

223

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Duodenal ferritin content and structure: relationship with body iron stores in man

10 October 2023

233

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Diagnostic Value of Marrow Hemosiderin Patterns

10 October 2023

240

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Haemochromatosis and superoxide metabolism: Free-radical influenced iron storage?

10 October 2023

244

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

The Measurement of Iron Absorption by the Double Isotope Technique

10 October 2023

246

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Ferritin in synovial cells in patients with rheumatoid arthritis

10 October 2023

252

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Circulating Iron-Containing Macrophages in Hemochromatosis

10 October 2023

253

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

A Method for the Investigation of Reticuloendothelial Iron Kinetics in Man

10 October 2023

257

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Thyroidectomy Increases Rat Hepatic Ferritin Iron

10 October 2023

271

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Biochemical changes in the tissues of animals injected with iron. 3. Lipid peroxidation

10 October 2023

276

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Lipid peroxide formation in microsomes. The role of non-haem iron

10 October 2023

279

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

The Effect of Ascorbic Acid Deficiency on Desferrioxamine-Induced Urinary Iron Excretion

10 October 2023

281

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Metabolic consequences of iron overload

10 October 2023

283

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Transferrin behaviour in primary haemochromatosis

10 October 2023

284

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Measurement of iron stores using deferoxamine

10 October 2023

286

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Evaluation of storage iron by chelates

10 October 2023

289

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

The differential ferrioxamine test in the management of idiopathic haemochromatosis

10 October 2023

291

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Solid phase radioimmunossay for serum ferritin

10 October 2023

296

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Ferritin in the Serum of Normal Subjects and Patients with Iron Deficiency and Iron Overload

10 October 2023

297

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

New kinetic role for serum ferritin in iron metabolism

10 October 2023

303

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

On the iron content of human serum ferritin, especially in acute viral hepaptitis and iron overload

10 October 2023

306

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Ferritin Turnover in Plasma: An Opportunistic Use of Blood Removed during Exchange Transfusion

10 October 2023

307

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

The Kinetics of Serum Ferritin

10 October 2023

309

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Ferritin synthesis by free and membrane-bound (poly)ribosomes of rat liver

10 October 2023

310

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Binding of Human Serum Ferritin to Concanavalin A

10 October 2023

315

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Sialic acid and the microheterogeneity of human serum ferritin

10 October 2023

316

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Binding of serum ferritin to concanavalin A: patients with homozygous beta thalassaemia and transfusional iron overload

10 October 2023

317

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Variability of serum ferritin concentration in normal subjects

10 October 2023

323

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Regulation of plasma ferritin by the isolated perfused rat liver

10 October 2023

325

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Serum ferritin in ascorbic acid deficiency

10 October 2023

328

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

The Relationship between Marrow Iron Stores, Plasma Ferritin Concentrations and Iron Absorption

10 October 2023

333

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

A family study of a patient with idiopathic hemochromatosis

10 October 2023

338

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Measurement of liver-iron concentration in needle-biopsy specimens

10 October 2023

341

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Magnetic-susceptibility measurement of human iron stores

10 October 2023

342

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Computed Tomography in the Diagnosis of Disorders of Excessive Iron Storage of the Liver

10 October 2023

343

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Computed tomography for determining liver iron content in primary haemochromatosis

10 October 2023

345

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Hemochromatosis and the skin

10 October 2023

347

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Cutaneous manifestations of idiopathic hemochromatosis. Study of 100 cases

10 October 2023

348

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

The Quarterly Journal of Medicine

10 October 2023

350

38

1

Williams R.

1969

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

[On iron-containing growth factors, sideramines, and their antagonists, the iron-containing antibiotics, sideromycins]

10 October 2023

353

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Long-term desferrioxamine therapy in thalassemia

10 October 2023

354

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Reassessment of the Use of Desferrioxamine B in Iron Overload

10 October 2023

356

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Continuous subcutaenous administration of deferoxamine in patients with iron overload

10 October 2023

357

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron-Loaded Subjects

10 October 2023

361

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

The Site of Action of Desferrioxamine

10 October 2023

362

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Chelation therapy in β-thalassemia major. III. The role of splenectomy in achieving iron balance

10 October 2023

367

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Ascorbic acid enhancement of desferrioxamine-induced urinary iron excretion in thalassemia major

10 October 2023

368

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Iron chelation with oral desferrioxamine

10 October 2023

372

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Iron chelation with oral desferrioxamine

10 October 2023

373

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Oral desferrioxamine in young patients with thalassaemia

10 October 2023

374

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Chelation studies with 2,3-dihydroxybenzoic acid in patients with beta-thalassaemia major

10 October 2023

375

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Journal of Pharmacology and Experimental Therapeutics

10 October 2023

379

196

478

Grady R. W.

1976

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Journal of Pharmacology and Experimental Therapeutics

10 October 2023

380

205

757

Grady R. W.

1978

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Journal of Pharmacology and Experimental Therapeutics

10 October 2023

381

208

12

Pitt C. G.

1979

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Effective Iron Chelation following Oral Administration of an Isoniazid-Pyridoxal Hydrazone

10 October 2023

382

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Liposome-encapsulated desferrioxamine in experimental iron overload

10 October 2023

386

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Clinical trial of desferrioxamine entrapped in red cell ghosts

10 October 2023

388

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Erythropoiesis and the Effect of Transfusion in Homozygous β-Thalassemia

10 October 2023

390

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

Evidence and mechanism for pectin-reduced intestinal inorganic iron absorption in idiopathic hemochromatosis

10 October 2023

393

1 reference

https://api.crossref.org/works/10.3109/10408368309165764

10 October 2023

Identifiers

1 reference

18 September 2017

1 reference